Starr, P. (2016). Idelalisib Improves Survival When Added to Bendamustine plus Rituximab in Patients with CLL. Am Health Drug Benefits.
Citación estilo ChicagoStarr, Phoebe. "Idelalisib Improves Survival When Added to Bendamustine Plus Rituximab in Patients With CLL." Am Health Drug Benefits 2016.
Cita MLAStarr, Phoebe. "Idelalisib Improves Survival When Added to Bendamustine Plus Rituximab in Patients With CLL." Am Health Drug Benefits 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.